- Published at
- by gurufocus.com
positive
positive
Hoth Therapeutics Announces Plans to Submit Expanded Access Application for HT-001 to Support Cancer Patients in Need
PR NewswireNEW YORK, March 10, 2025
HT-001 is being developed to alleviate the adverse dermatological effects experienced by cancer patients undergoing epi